Kestra Medical Technologies, Ltd.
KMTS
$26.07
-$0.33-1.25%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 51.55% | 71.40% | 82.31% | 169.58% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 51.55% | 71.40% | 82.31% | 169.58% | |
| Cost of Revenue | 22.58% | 10.89% | 15.49% | 50.59% | |
| Gross Profit | 110.74% | 446.39% | 643.98% | 538.64% | |
| SG&A Expenses | 75.42% | 181.50% | 39.23% | 10.12% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 54.58% | 115.26% | 26.46% | 15.07% | |
| Operating Income | -56.68% | -136.93% | -3.28% | 17.66% | |
| Income Before Tax | -26.96% | -128.63% | -0.63% | 19.03% | |
| Income Tax Expenses | 371.43% | 477.78% | 28.57% | -62.16% | |
| Earnings from Continuing Operations | -27.08% | -129.36% | -0.65% | 19.06% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -29.88% | -133.59% | 0.51% | 20.81% | |
| EBIT | -56.68% | -136.93% | -3.28% | 17.66% | |
| EBITDA | -67.23% | -175.28% | -12.84% | 19.87% | |
| EPS Basic | 55.05% | -84.39% | -5.98% | 99.55% | |
| Normalized Basic EPS | 49.03% | -106.96% | 1.21% | 99.56% | |
| EPS Diluted | 55.05% | -84.39% | -5.98% | 99.55% | |
| Normalized Diluted EPS | 49.03% | -106.96% | 1.21% | 99.56% | |
| Average Basic Shares Outstanding | 158.00% | 23.63% | 0.00% | 18,695.27% | |
| Average Diluted Shares Outstanding | 158.00% | 23.63% | 0.00% | 18,695.27% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |